Companies included in FTXH
This is FTXH's own dated portfolio constitution. Share counts are the calculation basis for constituent revenue and earnings analytics; rounded weights are reference values only. This page shows positions 1–51 of 51.
| Ticker | Issuer | Shares owned | Unit | Reported weight |
|---|---|---|---|---|
| JNJ | Johnson & Johnson | 8,893 | NS | 7.450831% |
| BMY | Bristol-Myers Squibb Company | 35,422 | NS | 7.363563% |
| MRK | Merck & Co., Inc | 17,843 | NS | 7.356675% |
| ABBV | AbbVie Inc. | 9,520 | NS | 7.096764% |
| LLY | Eli Lilly & Co. | 2,100 | NS | 6.620376% |
| PFE | Pfizer Inc. | 39,951 | NS | 3.845111% |
| REGN | Regeneron Pharmaceuticals, Inc. | 1,413 | NS | 3.741998% |
| BIIB | Biogen Inc | 5,759 | NS | 3.618802% |
| GILD | Gilead Sciences Inc. | 7,416 | NS | 3.542609% |
| CAH | Cardinal Health, Inc. | 4,819 | NS | 3.490287% |
| AMGN | Amgen Inc. | 2,846 | NS | 3.432232% |
| VTRS | Viatris Inc | 73,989 | NS | 3.426152% |
| ZTS | Zoetis Inc. | 8,426 | NS | 3.413971% |
| VRTX | Vertex Pharmaceuticals Incorporated | 2,223 | NS | 3.402389% |
| UTHR | United Therapeutics Corporation | 1,630 | NS | 3.312926% |
| INCY | Incyte Corporation. | 6,843 | NS | 2.20756% |
| JAZZ | Jazz Pharmaceuticals PLC | 3,347 | NS | 2.168785% |
| ILMN | Illumina Inc | 3,657 | NS | 1.54501% |
| EXEL | Exelixis, Inc. | 10,279 | NS | 1.511093% |
| MEDP | Medpace Holdings Inc. | 865 | NS | 1.423683% |
| PTCT | PTC Therapeutics, Inc. | 5,449 | NS | 1.272446% |
| CRL | Charles River Laboratories International, Inc. | 2,127 | NS | 1.257595% |
| BMRN | Biomarin Pharmaceutical Inc. | 6,318 | NS | 1.223307% |
| NBIX | Neurocrine Biosciences Inc | 2,630 | NS | 1.187565% |
| HALO | Halozyme Therapeutics Inc | 5,005 | NS | 1.108721% |
| ALKS | Alkermes PLC | 8,380 | NS | 1.015641% |
| ELAN | Elanco Animal Health Inc | 10,925 | NS | 0.896083% |
| SYRE | Spyre Therapeutics Inc | 3,533 | NS | 0.610805% |
| PTGX | Protagonist Therapeutics Inc | 1,650 | NS | 0.596086% |
| TGTX | TG Therapeutics Inc | 5,049 | NS | 0.574896% |
| ARWR | Arrowhead Pharmaceuticals Inc | 2,611 | NS | 0.561124% |
| CPRX | Catalyst Pharmaceuticals Inc. | 6,583 | NS | 0.558674% |
| AMRX | Amneal Pharmaceuticals Inc | 12,984 | NS | 0.553177% |
| RCUS | ARCUS BIOSCIENCES INC | 7,459 | NS | 0.552228% |
| TWST | Twist Bioscience Corporation | 3,238 | NS | 0.527397% |
| LGND | Ligand Pharmaceuticals Incorporated | 766 | NS | 0.524182% |
| MIRM | Mirum Pharmaceuticals Inc. | 1,646 | NS | 0.521185% |
| TVTX | Travere Therapeutics Inc | 5,100 | NS | 0.519346% |
| ALNY | Alnylam Pharmaceuticals Inc. | 456 | NS | 0.517138% |
| GH | Guardant Health Inc | 1,618 | NS | 0.512264% |
| ROIV | Roivant Sciences Ltd | 5,250 | NS | 0.498452% |
| MRNA | Moderna Inc | 2,836 | NS | 0.493803% |
| SUPN | Supernus Pharmaceuticals, Inc | 2,776 | NS | 0.491824% |
| KRYS | Krystal Biotech Inc | 551 | NS | 0.487858% |
| TARS | Tarsus Pharmaceuticals Inc | 2,012 | NS | 0.483771% |
| IONS | Ionis Pharmaceuticals, Inc. | 1,872 | NS | 0.481806% |
| TXG | 10X Genomics Inc | 6,591 | NS | 0.479607% |
| KYMR | Kymera Therapeutics Inc | 1,663 | NS | 0.474755% |
| ACAD | Acadia Pharmaceuticals Inc | 6,186 | NS | 0.471975% |
| ARQT | ARCUTIS BIOTHERAPEUTICS INC | 5,633 | NS | 0.454882% |
| MISXX | Dreyfus Government Cash Management Funds | 32,294.83 | NS | 0.110692% |
SEC N-PORT snapshot as of .